Literature DB >> 2433551

The antitumor effects of interferon.

I Gresser.   

Abstract

Interferons show antitumor activity in patients with various malignancies. The mechanism(s) of the antitumor effects are not altogether clear. In one experimental animal model discussed herein, mice were injected with Friend erythroleukemia cells and treated with mouse interferon alpha/beta. The results suggest that interferon does not act directly on the tumor cells but acts via host mechanisms that are still ill defined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433551     DOI: 10.1007/bf02934998

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  102 in total

1.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

2.  Interferon and cell division. VII. Inhibitory effect of highly purified interferon preparations on the multiplication of leukemia L 1210 cells.

Authors:  I Gresser; M T Bandu; M Tovey; G Bodo; K Paucker; W Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

3.  [The results of a combination of interferon and selective surgery in the treatment of osteosarcoma (author's transl)].

Authors:  U Nilsonne; H Strander
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1981

4.  Interferon for the therapy of condyloma acuminatum.

Authors:  S A Gall; C E Hughes; K Trofatter
Journal:  Am J Obstet Gynecol       Date:  1985-09-15       Impact factor: 8.661

5.  Evaluation of human lymphoblastoid interferon in advanced malignant melanoma.

Authors:  S Retsas; T J Priestman; K A Newton; G Westbury
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

6.  Interferon and laryngeal papillomatosis. The Iowa experience.

Authors:  B F McCabe; K F Clark
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Jan-Feb       Impact factor: 1.547

7.  Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.

Authors:  R S Freedman; J U Gutterman; J T Wharton; F N Rutledge
Journal:  J Biol Response Mod       Date:  1983

8.  Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.

Authors:  K A Foon; S A Sherwin; P G Abrams; D L Longo; M F Fer; H C Stevenson; J J Ochs; G C Bottino; C S Schoenberger; J Zeffren
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

9.  Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial.

Authors:  E C Borden; J F Holland; T L Dao; J U Gutterman; L Wiener; Y C Chang; J Patel
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

10.  Effects of intralesional interferon on neuroblastoma: changes in histology and DNA content distribution of tumor masses.

Authors:  T Sawada; T Takamatsu; T Tanaka; M Mino; K Fujita; T Kusunoki; N Arizono; M Fukuda; T Kishida
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

View more
  1 in total

Review 1.  JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.

Authors:  Katie L Owen; Natasha K Brockwell; Belinda S Parker
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.